Skip to content
Contact
0

Products

Home » Products

Showing 73–87 of 87 results

Vedolizumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
The IDKmonitor Vedolizumab Free Anti-drug ELISA kit is a microplate-based sandwich ELISA for the determination of free anti-vedolizumab antibodies in plasma or serum samples. Detecting high levels of free anti-vedolizumab antibodies in patients when the drug level is low (undetectable or sub-therapeutic) may indicate poorer long-term outcomes and suggest the need to switch treatment.

Rituximab Drug Level ELISA (IDKmonitor®)

Lab assay
The IDKmonitor Rituximab Drug Level ELISA kit is a microplate-based quantitative assay for the determination of free rituximab from plasma or serum samples. Rituximab is a chimeric therapeutic monoclonal antibody (mAb) that targets B-cells (CD-20) in the treatment of rheumatoid arthritis, non-Hodgkin's B-cell lymphomas, lymphocytic leukaemia, active granulomatosis with polyangiitis and microscopic polyangiitis. For research use only.

Vedolizumab Drug Level ELISA (IDKmonitor®)

Lab assay
Vedolizumab is a recombinant protein used to treat Crohn's disease and ulcerative colitis. The IDKmonitor Vedolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free vedolizumab in plasma or serum samples.

Ustekinumab Drug Level ELISA (IDKmonitor®)

Lab assay
Ustekinumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Ustekinumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free ustekinumab in plasma or serum samples.

Infliximab Total Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug (both free- nd bound antibodies) in serum and plasma.

Infliximab Drug Level ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples.

Golimumab Drug Level ELISA (IDKmonitor®)

Lab assay
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Golimumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free golimumab in plasma or serum samples. For research use only.

Etanercept Free Anti-drug Antibody ELISA (RUO) (IDKmonitor®)

Lab assay
IDKmonitor Etanercept Free Anti-drug Antibody ELISA is an assay that detects human antibodies against etanercept in EDTA plasma and serum samples. Etanercept is a human therapeutic monoclonal antibody used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis. For research use only.

Etanercept Drug Level ELISA (RUO) (IDKmonitor®)

Lab assay
The IDKmonitor Etanercept Drug Level ELISA is a microplate-based assay that allows quantitative determination of free etanercept from plasma or serum samples. Etanercept is a human therapeutic monoclonal antibody (mAb) used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis. For research use only.

Adalimumab Total Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat chronic inflammatory diseases. This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug (free- and bound- anti-drug antibodies) in serum and plasma.

Adalimumab Drug Level ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat inflammatory bowel disease (IBD) and other chronic inflammatory conditions. The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free adalimumab from plasma or serum samples.

Infliximab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation which is a major cause of loss of drug response. IDKmonitor Infliximab Free Anti-drug Antibody ELISA is an assay that detects human antibodies against infliximab in EDTA plasma and serum samples.

Golimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.

Adalimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat chronic inflammatory diseases. This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Free Anti-drug antibody ELISA detects free (non-drug bound) antibodies to Adalimumab in serum and plasma.

IDK® Oncostatin M ELISA

Lab assay
The IDK Oncostatin M (OSM) ELISA is for the quantitative determination of oncostatin M in serum, plasma or stool samples. OSM and its receptor, OSMR, are involved in gut inflammation, and are upregulated in the mucosa of IBD patients.

Showing 73–87 of 87 results

Show all products